General

Cartherics Announces Grant of European Patent

First patented product to enter clinic within two years 

Melbourne, Australia, 04 March 2021.

Cartherics Pty Ltd announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”.  The patent covers aspects of Cartherics’ chimeric antigen receptor (CAR) technology, particularly in relation to its CAR directed against the tumour-associated antigen, TAG-72.

This patent is […]

2021-03-09T10:51:27+11:00March 9th, 2021|

Cartherics CEO Alan Trounson remembers Dolly and welcomes Elizabeth Ann

Dolly the cloned sheep is a legend. Not so her technical descendant Elizabeth Ann the endangered black-footed ferret.

By Leigh Dayton

4 March 2021

In 1966 Alan Trounson was enjoying a hike in the hills above Edinburgh, Scotland with his colleague Ian Wilmut when Wilmut revealed a secret. His team at the Roslin Institute had cloned a […]

2021-03-04T11:35:02+11:00March 4th, 2021|

Cartherics welcomes new PhD Student

Monash Grad Rachelle Duffin joins the team

1 March 2021

By Leigh Dayton

Fresh from a Research Assistant job at the Peter MacCallum Cancer Centre and a Bachelor of Science (Honours) from Monash University, Rachelle Duffin took up her new role at Cartherics at the beginning of February.

She’s “delighted and honoured” to be supervised by Cartherics […]

2021-03-01T00:30:55+11:00March 1st, 2021|

Cartherics Makes February 2021 A Special Month

It all happened at Cape Schanck ……

By Leigh Dayton

24 February 2021

2020 was a rough year everywhere for everyone, including Cartherics’ hard-working team. By way of a thank you CEO Alan Trounson, Chairman Bob Moses and Chief Operating Officer Ian Nisbet hosted a company come-one come-all event this month at the Royal Automobile Club […]

2021-02-24T06:25:41+11:00February 24th, 2021|

CAR-T Funding is Reaching Staggering New Heights

A survey reveals nearly US$100 market capitalisation

23 February 2021

A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.

At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]

2021-02-24T06:18:44+11:00February 23rd, 2021|

Cartherics CEO Alan Trounson on “3-person IVF”

Legislation to be introduced to Australian Parliament

By Leigh Dayton

4 February 2021

Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.

Thanks to this […]

2021-02-04T03:41:18+11:00February 4th, 2021|

Cartherics Celebrates Academic Achievements

Doctoral students achieve key milestones

 By Leigh Dayton

21 December 2020

As a rough year for all comes to an end, Cartherics is delighted to raise a toast to Anisha Balachandran and Van Thi To.  Anisha dressed-up for a pared-down graduation ceremony, and Van passed her Confirmation of Candidature Review with flying colours.

Cartherics CEO Alan Trounson is the […]

2020-12-21T06:35:40+11:00December 21st, 2020|

The Power Of The Pivot – Lessons from the biotech frontline

Back People Not Projects

By Ian Nisbet*

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)

In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]

2020-11-19T01:14:44+11:00November 19th, 2020|

The Fight Against Cancer Continues ……. Despite COVID-19

18 November 2020

By Leigh Dayton

They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.

Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]

2020-12-09T09:26:07+11:00November 18th, 2020|

Cartherics CEO handed the editorial chair

Alan Trounson guest edits a special immunology issue of the journal Cells

 By Leigh Dayton 9 Nov 2020

 

As well as steering the Melbourne-based biotech company through the challenges of COVID-19, CEO Alan Trounson has taken up the role of guest editor for the prestigious journal Cells.

It’s a perfect match. The journal’s upcoming special issue will […]

2020-12-09T09:28:02+11:00November 9th, 2020|